Mehta Vimal (CIK 0001733369)

Latest company ownership

Shares held
7,687,501
Last filed at
Sep 17, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 14, 2024 Dec 17, 2024 BioXcel Therapeutics, Inc. CEO Sell 58.8 -3,117 -0.04% ✓ $1.1K
Sep 14, 2024 Sep 17, 2024 BioXcel Therapeutics, Inc. CEO Sell 58.8 -1,982 -0.03% ✓ $1.4K
Jun 14, 2024 Jun 18, 2024 BioXcel Therapeutics, Inc. CEO Sell 58.8 -2,134 -0.03% ✓ $2.7K
Jun 4, 2024 Jun 6, 2024 BioXcel Therapeutics, Inc. CEO Sell 20.0 -1,427,494 -15.59% ✗ $405.1K
Mar 14, 2024 Apr 8, 2024 BioXcel Therapeutics, Inc. CEO Sell 55.0 -5,268 -0.06% ✓ $13.8K
Jun 14, 2023 Jun 16, 2023 BioXcel Therapeutics, Inc. CEO Sell 10.0 -60,000 -21.80% ✓ $1.3M
May 22, 2023 May 24, 2023 BioXcel Therapeutics, Inc. CEO Sell 25.0 -6,500 -14.19% ✓ $167.6K
Mar 20, 2023 Mar 22, 2023 BioXcel Therapeutics, Inc. CEO Sell 42.5 -64,500 -0.74% ✓ $1.2M
Dec 15, 2022 Dec 19, 2022 BioXcel Therapeutics, Inc. CEO Sell 42.5 -60,000 -0.69% ✓ $1.2M
Jun 25, 2021 Jun 29, 2021 BioXcel Therapeutics, Inc. CEO Sell 15.0 -473,250 -5.24% ✗ $14.6M
Mar 12, 2018 Feb 16, 2021 BioXcel Therapeutics, Inc. CEO Sell 27.5 -78,000 -0.85% ✗ $4.8M
Feb 24, 2020 May 13, 2020 BioXcel Therapeutics, Inc. CEO Sell 16.3 -300,000 -3.16% ✗ $9M
Aug 16, 2019 Aug 19, 2019 BioXcel Therapeutics, Inc. CEO Buy 90.0 +974 10.84% ✗ $8.7K
Aug 14, 2019 Aug 16, 2019 BioXcel Therapeutics, Inc. CEO Buy 91.3 +2,983 49.72% ✗ $25.8K
Aug 13, 2019 Aug 14, 2019 BioXcel Therapeutics, Inc. CEO Buy 90.0 +1,000 20.00% ✗ $8.8K
Dec 14, 2018 Dec 14, 2018 BioXcel Therapeutics, Inc. CEO Buy 90.0 +2,000 66.67% ✗ $8.8K
Dec 4, 2018 Dec 4, 2018 BioXcel Therapeutics, Inc. CEO Buy 90.0 +1,000 50.00% ✗ $5.1K
Dec 3, 2018 Dec 4, 2018 BioXcel Therapeutics, Inc. CEO Buy 90.0 +1,000 100.00% ✗ $5.2K
Nov 30, 2018 Nov 30, 2018 BioXcel Therapeutics, Inc. CEO Buy 90.0 +1,000 100.00% ✗ $5.1K